CRISPR Therapeutics (NASDAQ:CRSP) gained 18.7% Thursday, Intellia Therapeutics (NASDAQ:NTLA) rose 16.1% and Editas Medicine ...
Source link
CRISPR Therapeutics (NASDAQ:CRSP) gained 18.7% Thursday, Intellia Therapeutics (NASDAQ:NTLA) rose 16.1% and Editas Medicine ...
Source link